Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential.

Crispens MA, Bodurka D, Deavers M, Lu K, Silva EG, Gershenson DM
Obstet Gynecol. 2002 99 (1): 3-10

PMID: 11777502 · DOI:10.1016/s0029-7844(01)01649-0

MeSH Terms (19)

Adult Aged Age Distribution Antineoplastic Combined Chemotherapy Protocols Biopsy, Needle Cystadenocarcinoma, Serous Disease-Free Survival Disease Progression Female Humans Middle Aged Neoplasm Recurrence, Local Neoplasm Staging Ovarian Neoplasms Probability Prognosis Retrospective Studies Survival Analysis Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: